Company Filing History:
Years Active: 2011-2012
Title: Kelsea M Shoop: Innovator in Monoclonal Antibodies
Introduction
Kelsea M Shoop is a prominent inventor based in Oregon City, OR (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents, her work focuses on innovative solutions for detecting and treating pancreatic conditions.
Latest Patents
Kelsea's latest patents revolve around isolated monoclonal antibodies that specifically bind to cell surface antigens expressed on human pancreatic endocrine and exocrine cells. These antibodies are designed to detect and isolate pancreatic cells, which can be crucial for diagnosing conditions such as diabetes or pancreatic tumors. The patents also describe methods for treating pancreatic tumors using these antibodies, which can be conjugated to effector molecules or detectable markers for enhanced functionality.
Career Highlights
Kelsea M Shoop is affiliated with Oregon Health & Science University, where she conducts her research and development work. Her innovative approach to monoclonal antibodies has positioned her as a key figure in the biotechnology sector, contributing to advancements in medical diagnostics and therapeutics.
Collaborations
Some of Kelsea's notable coworkers include Markus Grompe and Philip R Streeter. Their collaborative efforts have further enhanced the research and development of monoclonal antibodies, leading to impactful innovations in the field.
Conclusion
Kelsea M Shoop's work in monoclonal antibodies exemplifies the intersection of innovation and healthcare. Her contributions are paving the way for new diagnostic and therapeutic options for pancreatic conditions, showcasing the importance of research in improving patient outcomes.